Meiji

Overview

Meiji Holdings is a leading Japanese food and pharmaceutical company famous for its chocolate, dairy products, and confectionery, with a dual business model spanning consumer foods and pharmaceutical manufacturing.

Historical Timeline

• 1916: Meiji Seika (confectionery) and Meiji Dairyu (dairy) founded separately
• 1926: Launches Meiji Milk Chocolate — Japan's first domestically produced chocolate bar
• 1960s: Becomes Japan's #1 chocolate brand
• 2009: Merges Meiji Seika and Meiji Dairyu into Meiji Holdings
• 2012: Pharmaceutical division spun into Meiji Seika Pharma
• 2024: Announces cocoa sustainability program targeting 100% traceable sourcing

Business Model

Two segments: Food Products (70% — chocolate, dairy, confectionery, nutrition) and Pharmaceuticals (30% — OTC drugs, prescription medicines, vaccines). Revenue from domestic Japanese market (80%) and growing international sales (20%, focused on Asia).

Moat Analysis

Meiji Chocolate is #1 in Japan with 40%+ market share — 'Meiji no Milk Chocolate' is a cultural institution. Dual food-pharma model provides revenue stability. R&D in probiotics and functional foods leverages pharmaceutical expertise for consumer products.

Key Data

• revenue: ~¥1.4 trillion (~$9.5B) (2023)
• chocolate_share: ~40% Japan market
• employees: ~17,000
• pharma_revenue: ~30% of total
• international: ~20% of revenue

Interesting Facts

• Meiji's 'Apollo' strawberry-shaped chocolate has been Japan's most popular valentine's gift for over 50 years — it is practically a cultural institution.
• Meiji produces a probiotic yogurt drink called 'Meiji R-1' that became so popular during COVID that the Japanese government had to ask stores to limit purchases.